nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—Vismodegib—skin cancer	0.205	0.23	CbGbCtD
MACITENTAN—ALB—Vemurafenib—skin cancer	0.162	0.182	CbGbCtD
MACITENTAN—CYP2C19—Vismodegib—skin cancer	0.133	0.149	CbGbCtD
MACITENTAN—CYP3A4—Imiquimod—skin cancer	0.0928	0.104	CbGbCtD
MACITENTAN—CYP3A4—Temozolomide—skin cancer	0.0928	0.104	CbGbCtD
MACITENTAN—ALB—Fluorouracil—skin cancer	0.0729	0.0818	CbGbCtD
MACITENTAN—CYP3A4—Vismodegib—skin cancer	0.0643	0.0721	CbGbCtD
MACITENTAN—CYP3A4—Vemurafenib—skin cancer	0.0508	0.057	CbGbCtD
MACITENTAN—CYP3A4—Docetaxel—skin cancer	0.0174	0.0196	CbGbCtD
MACITENTAN—Hepatotoxicity—Vemurafenib—skin cancer	0.00536	0.0667	CcSEcCtD
MACITENTAN—Hepatotoxicity—Dactinomycin—skin cancer	0.00303	0.0377	CcSEcCtD
MACITENTAN—Hepatotoxicity—Temozolomide—skin cancer	0.00274	0.0341	CcSEcCtD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.00243	0.086	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Vismodegib—skin cancer	0.00234	0.0292	CcSEcCtD
MACITENTAN—Infestation NOS—Vemurafenib—skin cancer	0.00231	0.0288	CcSEcCtD
MACITENTAN—Infestation—Vemurafenib—skin cancer	0.00231	0.0288	CcSEcCtD
MACITENTAN—Influenza—Imiquimod—skin cancer	0.00221	0.0276	CcSEcCtD
MACITENTAN—Bronchitis—Imiquimod—skin cancer	0.00213	0.0265	CcSEcCtD
MACITENTAN—Infestation NOS—Imiquimod—skin cancer	0.00197	0.0246	CcSEcCtD
MACITENTAN—Infestation—Imiquimod—skin cancer	0.00197	0.0246	CcSEcCtD
MACITENTAN—Urinary tract infection—Imiquimod—skin cancer	0.00192	0.0239	CcSEcCtD
MACITENTAN—Angiopathy—Vemurafenib—skin cancer	0.00188	0.0235	CcSEcCtD
MACITENTAN—Hepatotoxicity—Docetaxel—skin cancer	0.00182	0.0227	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—MC1R—skin cancer	0.0018	0.0635	CbGpPWpGaD
MACITENTAN—Pharyngitis—Imiquimod—skin cancer	0.00176	0.0219	CcSEcCtD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.00174	0.0615	CbGpPWpGaD
MACITENTAN—Angiopathy—Imiquimod—skin cancer	0.00161	0.02	CcSEcCtD
MACITENTAN—Infection—Vemurafenib—skin cancer	0.00147	0.0183	CcSEcCtD
MACITENTAN—Nervous system disorder—Vemurafenib—skin cancer	0.00145	0.018	CcSEcCtD
MACITENTAN—Hypotension—Vemurafenib—skin cancer	0.00138	0.0172	CcSEcCtD
MACITENTAN—Fluid retention—Docetaxel—skin cancer	0.00133	0.0166	CcSEcCtD
MACITENTAN—EDNRA—Peptide GPCRs—MC1R—skin cancer	0.00129	0.0454	CbGpPWpGaD
MACITENTAN—Bronchitis—Temozolomide—skin cancer	0.00128	0.0159	CcSEcCtD
MACITENTAN—Nasopharyngitis—Fluorouracil—skin cancer	0.00126	0.0157	CcSEcCtD
MACITENTAN—Oedema—Imiquimod—skin cancer	0.00126	0.0157	CcSEcCtD
MACITENTAN—Infection—Imiquimod—skin cancer	0.00125	0.0156	CcSEcCtD
MACITENTAN—Nervous system disorder—Imiquimod—skin cancer	0.00123	0.0154	CcSEcCtD
MACITENTAN—Infestation NOS—Temozolomide—skin cancer	0.00118	0.0147	CcSEcCtD
MACITENTAN—Infestation—Temozolomide—skin cancer	0.00118	0.0147	CcSEcCtD
MACITENTAN—Pharyngitis—Dactinomycin—skin cancer	0.00116	0.0145	CcSEcCtD
MACITENTAN—Urinary tract infection—Temozolomide—skin cancer	0.00115	0.0143	CcSEcCtD
MACITENTAN—Infestation NOS—Fluorouracil—skin cancer	0.00109	0.0136	CcSEcCtD
MACITENTAN—Infestation—Fluorouracil—skin cancer	0.00109	0.0136	CcSEcCtD
MACITENTAN—Urinary tract infection—Fluorouracil—skin cancer	0.00106	0.0132	CcSEcCtD
MACITENTAN—Pharyngitis—Temozolomide—skin cancer	0.00105	0.0131	CcSEcCtD
MACITENTAN—Anaemia—Bleomycin—skin cancer	0.00101	0.0126	CcSEcCtD
MACITENTAN—EDNRA—EGFR-dependent Endothelin signaling events—HRAS—skin cancer	0.000981	0.0346	CbGpPWpGaD
MACITENTAN—Pharyngitis—Fluorouracil—skin cancer	0.00097	0.0121	CcSEcCtD
MACITENTAN—Angiopathy—Temozolomide—skin cancer	0.000963	0.012	CcSEcCtD
MACITENTAN—Anaemia—Dactinomycin—skin cancer	0.000944	0.0118	CcSEcCtD
MACITENTAN—Headache—Vemurafenib—skin cancer	0.000924	0.0115	CcSEcCtD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	0.000919	0.0324	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Docetaxel—skin cancer	0.000912	0.0114	CcSEcCtD
MACITENTAN—Oedema—Bleomycin—skin cancer	0.000894	0.0111	CcSEcCtD
MACITENTAN—Infection—Bleomycin—skin cancer	0.000888	0.0111	CcSEcCtD
MACITENTAN—Anaemia—Temozolomide—skin cancer	0.000854	0.0106	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—MC1R—skin cancer	0.000846	0.0299	CbGpPWpGaD
MACITENTAN—Hypotension—Bleomycin—skin cancer	0.000835	0.0104	CcSEcCtD
MACITENTAN—Oedema—Dactinomycin—skin cancer	0.000834	0.0104	CcSEcCtD
MACITENTAN—Infection—Dactinomycin—skin cancer	0.000828	0.0103	CcSEcCtD
MACITENTAN—Headache—Imiquimod—skin cancer	0.000788	0.00982	CcSEcCtD
MACITENTAN—Anaemia—Fluorouracil—skin cancer	0.000787	0.0098	CcSEcCtD
MACITENTAN—Infestation—Docetaxel—skin cancer	0.000786	0.00979	CcSEcCtD
MACITENTAN—Infestation NOS—Docetaxel—skin cancer	0.000786	0.00979	CcSEcCtD
MACITENTAN—Oedema—Temozolomide—skin cancer	0.000754	0.00939	CcSEcCtD
MACITENTAN—Infection—Temozolomide—skin cancer	0.000749	0.00933	CcSEcCtD
MACITENTAN—Nervous system disorder—Temozolomide—skin cancer	0.000739	0.00921	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Other—SMO—skin cancer	0.000737	0.026	CbGpPWpGaD
MACITENTAN—Pharyngitis—Docetaxel—skin cancer	0.0007	0.00872	CcSEcCtD
MACITENTAN—Oedema—Fluorouracil—skin cancer	0.000695	0.00865	CcSEcCtD
MACITENTAN—Infection—Fluorouracil—skin cancer	0.00069	0.0086	CcSEcCtD
MACITENTAN—Nervous system disorder—Fluorouracil—skin cancer	0.000681	0.00849	CcSEcCtD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.000662	0.0234	CbGpPWpGaD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	0.000658	0.0232	CbGpPWpGaD
MACITENTAN—Hypotension—Fluorouracil—skin cancer	0.000649	0.00809	CcSEcCtD
MACITENTAN—Angiopathy—Docetaxel—skin cancer	0.00064	0.00798	CcSEcCtD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.000632	0.0223	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—MC1R—skin cancer	0.000605	0.0214	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—PTCH2—skin cancer	0.000597	0.0211	CbGpPWpGaD
MACITENTAN—Anaemia—Docetaxel—skin cancer	0.000568	0.00707	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000567	0.02	CbGpPWpGaD
MACITENTAN—Oedema—Docetaxel—skin cancer	0.000501	0.00625	CcSEcCtD
MACITENTAN—Infection—Docetaxel—skin cancer	0.000498	0.0062	CcSEcCtD
MACITENTAN—Nervous system disorder—Docetaxel—skin cancer	0.000492	0.00612	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.000474	0.0167	CbGpPWpGaD
MACITENTAN—Headache—Temozolomide—skin cancer	0.000472	0.00588	CcSEcCtD
MACITENTAN—Hypotension—Docetaxel—skin cancer	0.000469	0.00584	CcSEcCtD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000435	0.0154	CbGpPWpGaD
MACITENTAN—Headache—Fluorouracil—skin cancer	0.000435	0.00542	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—MC1R—skin cancer	0.000432	0.0153	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—PTCH2—skin cancer	0.000428	0.0151	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000406	0.0143	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000373	0.0132	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RHOU—skin cancer	0.000371	0.0131	CbGpPWpGaD
MACITENTAN—Headache—Docetaxel—skin cancer	0.000314	0.00391	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000312	0.011	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—MC1R—skin cancer	0.000309	0.0109	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—SHH—skin cancer	0.000308	0.0109	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PTCH2—skin cancer	0.000307	0.0108	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—PTCH1—skin cancer	0.000292	0.0103	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—SMO—skin cancer	0.000292	0.0103	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—HRAS—skin cancer	0.000289	0.0102	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—PTGER4—skin cancer	0.000284	0.01	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000267	0.00943	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RHOU—skin cancer	0.000265	0.00937	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—MC1R—skin cancer	0.000244	0.00862	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MC1R—skin cancer	0.000222	0.00783	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—SHH—skin cancer	0.00022	0.00778	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTCH2—skin cancer	0.000219	0.00775	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—PTCH1—skin cancer	0.000209	0.00737	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—SMO—skin cancer	0.000209	0.00737	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—HRAS—skin cancer	0.000207	0.0073	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—PTGER4—skin cancer	0.000203	0.00718	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTCH2—skin cancer	0.000181	0.00639	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—MC1R—skin cancer	0.000175	0.00617	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PTGER4—skin cancer	0.000161	0.00567	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MC1R—skin cancer	0.000159	0.0056	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—SHH—skin cancer	0.000158	0.00558	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000153	0.00539	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—SMO—skin cancer	0.00015	0.00529	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PTCH1—skin cancer	0.00015	0.00529	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000148	0.00522	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PTGER4—skin cancer	0.000146	0.00515	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GLI2—skin cancer	0.000137	0.00485	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MC1R—skin cancer	0.000131	0.00462	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTCH2—skin cancer	0.00013	0.00458	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GLI1—skin cancer	0.000129	0.00456	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000127	0.00449	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SUFU—skin cancer	0.000122	0.00432	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PTGER4—skin cancer	0.000115	0.00406	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—SHH—skin cancer	0.000113	0.00399	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000108	0.00382	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTCH1—skin cancer	0.000107	0.00378	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—SMO—skin cancer	0.000107	0.00378	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000106	0.00374	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTGER4—skin cancer	0.000104	0.00368	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000104	0.00366	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	0.000103	0.00364	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GLI2—skin cancer	9.82e-05	0.00347	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MC1R—skin cancer	9.37e-05	0.00331	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SHH—skin cancer	9.33e-05	0.00329	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RASA1—skin cancer	9.27e-05	0.00327	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GLI1—skin cancer	9.24e-05	0.00326	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	9.11e-05	0.00322	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTCH1—skin cancer	8.84e-05	0.00312	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SMO—skin cancer	8.84e-05	0.00312	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SUFU—skin cancer	8.76e-05	0.00309	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTGER4—skin cancer	8.61e-05	0.00304	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.6e-05	0.00304	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.75e-05	0.00274	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	7.74e-05	0.00273	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.72e-05	0.00273	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FOXO4—skin cancer	7.61e-05	0.00269	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.41e-05	0.00262	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	7.31e-05	0.00258	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SHH—skin cancer	6.68e-05	0.00236	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RASA1—skin cancer	6.64e-05	0.00234	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SMO—skin cancer	6.33e-05	0.00224	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTCH1—skin cancer	6.33e-05	0.00224	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTGER4—skin cancer	6.16e-05	0.00218	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—skin cancer	6.16e-05	0.00217	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—skin cancer	5.47e-05	0.00193	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FOXO4—skin cancer	5.44e-05	0.00192	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TERT—skin cancer	5.08e-05	0.00179	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—skin cancer	5.01e-05	0.00177	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—NRAS—skin cancer	4.28e-05	0.00151	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BRAF—skin cancer	4.02e-05	0.00142	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—skin cancer	3.98e-05	0.00141	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PLIN2—skin cancer	3.83e-05	0.00135	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—KRAS—skin cancer	3.68e-05	0.0013	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TERT—skin cancer	3.64e-05	0.00128	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PLIN2—skin cancer	3.44e-05	0.00121	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HRAS—skin cancer	3.13e-05	0.00111	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CSPG4—skin cancer	3.09e-05	0.00109	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—NRAS—skin cancer	3.06e-05	0.00108	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—skin cancer	3e-05	0.00106	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BRAF—skin cancer	2.88e-05	0.00102	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CSPG4—skin cancer	2.77e-05	0.000979	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—KRAS—skin cancer	2.64e-05	0.000931	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NRAS—skin cancer	2.53e-05	0.000893	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HRAS—skin cancer	2.24e-05	0.000791	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KRAS—skin cancer	2.18e-05	0.000768	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—skin cancer	2.14e-05	0.000757	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ENO2—skin cancer	2.1e-05	0.000741	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PLIN2—skin cancer	2.07e-05	0.00073	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—skin cancer	1.93e-05	0.000683	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ENO2—skin cancer	1.88e-05	0.000665	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HRAS—skin cancer	1.85e-05	0.000653	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NRAS—skin cancer	1.81e-05	0.000639	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—skin cancer	1.77e-05	0.000625	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CSPG4—skin cancer	1.67e-05	0.000589	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.64e-05	0.00058	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KRAS—skin cancer	1.56e-05	0.00055	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.47e-05	0.00052	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NRAS—skin cancer	1.4e-05	0.000495	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—skin cancer	1.38e-05	0.000489	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HRAS—skin cancer	1.32e-05	0.000467	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—skin cancer	1.27e-05	0.000447	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ERCC2—skin cancer	1.22e-05	0.00043	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KRAS—skin cancer	1.21e-05	0.000426	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ENO2—skin cancer	1.13e-05	0.0004	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ERCC2—skin cancer	1.09e-05	0.000386	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—skin cancer	1.07e-05	0.000379	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HRAS—skin cancer	1.03e-05	0.000362	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—skin cancer	7.31e-06	0.000258	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ERCC2—skin cancer	6.58e-06	0.000232	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—skin cancer	6.56e-06	0.000232	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—skin cancer	3.95e-06	0.000139	CbGpPWpGaD
